What should the initial management of atypical hyperplasia be?
**Core Concept**
Atypical hyperplasia refers to the abnormal growth of cells in a glandular tissue, often a precursor to cancer. It is a condition where the cells exhibit some features of cancer but not enough to be classified as invasive cancer. The initial management of atypical hyperplasia is crucial in preventing the progression to invasive cancer.
**Why the Correct Answer is Right**
The initial management of atypical hyperplasia involves a combination of medical and surgical interventions. The correct approach is to remove the affected tissue through a procedure called a hysterectomy or endometrial ablation, depending on the patient's age and medical history. This is because atypical hyperplasia is a high-risk condition for developing into endometrial cancer. The surgical removal of the affected tissue can help prevent the progression of atypical hyperplasia to invasive cancer.
**Why Each Wrong Option is Incorrect**
**Option A:** Medical management with hormone replacement therapy (HRT) is not the initial management of atypical hyperplasia. HRT may actually worsen the condition by stimulating cell growth.
**Option B:** Observation and watchful waiting are not appropriate for atypical hyperplasia, as it is a high-risk condition for developing into invasive cancer.
**Option C:** Biopsy alone is not sufficient for the initial management of atypical hyperplasia, as it may not provide a complete picture of the extent of the disease.
**Clinical Pearl / High-Yield Fact**
Atypical hyperplasia is a precursor to endometrial cancer, and the risk of progression to invasive cancer is higher in patients with atypical hyperplasia than in those with normal endometrium.
**Correct Answer: C. Surgical removal of the affected tissue.**